← FDA Drug Approvals (Drugs@FDA)

FRUZAQLA

NDA · New Drug Application · Sponsor: TAKEDA PHARMS USA · Approved 2023-11-08

Drug application

FDA Application #

NDA217564

Application type

New Drug Application

Brand name

FRUZAQLA

Generic name

FRUQUINTINIB

Active ingredients

FRUQUINTINIB

Dosage form

CAPSULE

Route

ORAL

Marketing status

Prescription

Sponsor

TAKEDA PHARMS USA

Manufacturer

Takeda Pharmaceuticals America, Inc.

First approval

2023-11-08

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown